US Patent 10981901 Heterocyclic amides useful as protein modulators

Patent 10981901 was granted and assigned to GlaxoSmithKline on April, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

GlaxoSmithKline

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

109819010

Patent Inventor Names

Jianxing Kang0

Joseph J. Romano0

Date of Patent

April 20, 2021

Patent Application Number

160911890

Date Filed

April 5, 2017

Patent Citations Received

‌

US Patent 11377440 Modulators of stimulator of interferon genes (STING)

‌

US Patent 11365190 Heterocyclic amides useful as protein modulators

Patent Primary Examiner

‌

Kristin A Vajda

Patent abstract

Disclosed are compounds having the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10981901 Heterocyclic amides useful as protein modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API